{"id":360960,"date":"2025-08-30T16:07:29","date_gmt":"2025-08-30T16:07:29","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-immunocore-holdings\/"},"modified":"2025-08-30T16:07:29","modified_gmt":"2025-08-30T16:07:29","slug":"how-to-buy-immunocore-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/","title":{"rendered":"How to buy Immunocore Holdings plc (IMCR) shares &#8211; Investment in Immunocore Holdings plc (IMCR) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-360960","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Immunocore Holdings plc (IMCR) Shares - Investment in Immunocore Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Immunocore Holdings plc (IMCR) Shares - Investment in Immunocore Stock"},"description":"Learn how to buy Immunocore Holdings plc (IMCR) shares with our complete investment guide. Discover current price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Immunocore Holdings plc (IMCR) shares with our complete investment guide. Discover current price, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in cutting-edge cancer immunotherapy? Immunocore Holdings (IMCR) represents the future of precision medicine with their revolutionary ImmTAX platform. This British-American biotech pioneer has already changed lives with their FDA-approved TCR therapy, and they're just getting started. Let's explore why this stock deserves your attention and how you can become part of their growth story.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in cutting-edge cancer immunotherapy? Immunocore Holdings (IMCR) represents the future of precision medicine with their revolutionary ImmTAX platform. This British-American biotech pioneer has already changed lives with their FDA-approved TCR therapy, and they're just getting started. Let's explore why this stock deserves your attention and how you can become part of their growth story."},"body_html":"<h2>\ud83d\udcc8 Immunocore Stock: Current Price and Market Position<\/h2> <p>As of August 30, 2025, Immunocore Holdings plc (IMCR) trades at <strong>$32.65<\/strong> on the NASDAQ exchange. The company has demonstrated remarkable resilience in the volatile biotech sector, maintaining a strong cash position of <strong>$883 million<\/strong> while driving impressive revenue growth.<\/p> <p><strong>Mark your calendar: November 5, 2025<\/strong> is absolutely critical for IMCR investors. That's when the company releases its Q3 earnings report, and historically, these announcements create significant price movements.<\/p> <h3>How Earnings Reports Move IMCR Stock<\/h3> <p>Immunocore has built a reputation for beating analyst expectations. Their Q2 2025 results showed an earnings per share of -$0.20, exceeding consensus estimates of -$0.21 by $0.01. Even more impressive was their previous quarter where they delivered $0.10 per share, smashing the expected -$0.35 with a stunning <strong>128.57% positive surprise<\/strong> (<a href=\"https:\/\/tickernerd.com\/stock\/imcr-forecast\/\">Tickernerd<\/a>).<\/p> <p>The pattern is clear: when Immunocore beats expectations, the market rewards them. Their Q2 2025 revenue reached $130.65 million, representing a <strong>30% year-over-year increase<\/strong> and exceeding consensus estimates of $122.96 million (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/IMCR\/earnings\/\">MarketBeat<\/a>).<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Volatility Analysis<\/h2> <p>Immunocore shares have navigated a challenging but ultimately stable path over the past six months. The stock has traded within a <strong>52-week range of $23.15 to $39.33<\/strong>, with the current price positioned near the middle of this range (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/IMCR\/immunocore-holdings\/stock-price-history\">Macrotrends<\/a>).<\/p> <p><strong>Key volatility insights:<\/strong><\/p> <ul> <li>Daily volatility averages <strong>2.47%<\/strong> over the past week<\/li> <li>Weekly volatility sits at <strong>4.5%<\/strong>, significantly lower than the biotech industry average of 10.6%<\/li> <li>The stock shows only <strong>47% green days<\/strong> over the past month with 10.27% price volatility<\/li> <\/ul> <p>Despite some downward pressure, IMCR has maintained <strong>technical support at $35.63<\/strong> based on volume accumulation, providing a potential buying opportunity if tested (<a href=\"https:\/\/stockinvest.us\/stock\/IMCR\">StockInvest<\/a>).<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <h3>Near-Term Projections (2025-2026)<\/h3> <p>For 2025, analysts project an <strong>average price target of $47.23<\/strong>, with optimistic scenarios reaching <strong>$65.65<\/strong> and conservative estimates around <strong>$28.80<\/strong> (<a href=\"https:\/\/stockscan.io\/stocks\/IMCR\/forecast\">Stockscan<\/a>). The current analyst consensus among 7 experts is a <strong>\"Buy\" rating with an average target of $57<\/strong> - representing a potential <strong>74.58% upside<\/strong> from current levels.<\/p> <h3>Medium to Long-Term Forecast<\/h3> <ul> <li><strong>2026<\/strong>: Expected to continue growth trajectory toward $50-60 range<\/li> <li><strong>2028<\/strong>: Projected to reach $70-85 as pipeline products mature<\/li> <li><strong>2030<\/strong>: Analysts forecast <strong>$90.85<\/strong> based on platform expansion and market penetration<\/li> <\/ul> <p><strong>Verdict: STRONG BUY<\/strong> for long-term investors. The combination of strong revenue growth, expanding pipeline, and massive addressable markets makes IMCR an compelling opportunity for patient capital.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>High RSI<\/strong>: Current RSI14 reading of <strong>81<\/strong> indicates overbought conditions<\/li> <li><strong>Profitability challenges<\/strong>: Negative EPS of -$0.41 and forward P\/E of -26.71<\/li> <li><strong>Clinical trial risks<\/strong>: Phase 3 trials carry inherent uncertainty<\/li> <li><strong>Regulatory hurdles<\/strong>: FDA approvals can be unpredictable in biotech<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Revenue explosion<\/strong>: KIMMTRAK sales grew <strong>30% year-over-year<\/strong> to $98.0 million in Q2<\/li> <li><strong>Cash fortress<\/strong>: $883 million war chest provides 5+ years of runway<\/li> <li><strong>Pipeline progress<\/strong>: Phase 3 TEBE-AM trial on track for H1 2026 completion<\/li> <li><strong>Industry tailwinds<\/strong>: Cancer immunotherapy market growing at 15% annually<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong>: Begin with a position size that represents \u22645% of your portfolio<\/li> <li><strong>Dollar-cost average<\/strong>: Invest fixed amounts monthly to avoid timing mistakes<\/li> <li><strong>Set price alerts<\/strong>: Monitor around November 5 earnings for potential entry points<\/li> <li><strong>Think long-term<\/strong>: Biotech investments require 3-5 year time horizons<\/li> <\/ol> <p>Humorous take: \"Trading IMCR is like watching a clinical trial - 90% waiting, 10% excitement, but when it works, it really works!\"<\/p> <h2>\u2705 How to Buy Immunocore Holdings plc (IMCR) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ access and reasonable fees<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Typically requires ID and proof of address<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>4<\/td><td>Search \"IMCR\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Use limit orders to control entry price<\/td><\/tr> <tr><td>6<\/td><td>Review and confirm<\/td><td>Check commission rates before finalizing<\/td><\/tr> <tr><td>7<\/td><td>Monitor your position<\/td><td>Set stop-losses and profit targets<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>Pocket Option makes stock investing accessible for everyone:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - perfect for testing strategies risk-free<\/li> <li><strong>1-minute KYC process<\/strong> - upload any ID document and start trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong> - including cryptocurrencies, e-wallets, and bank cards<\/li> <li><strong>Fractional shares available<\/strong> - invest in expensive stocks with small amounts<\/li> <\/ul> <p>The platform's user-friendly interface and educational resources make it ideal for beginners learning how to buy Immunocore Holdings plc (IMCR) shares and other biotech stocks.<\/p> <h2>\ud83c\udf0d Immunocore in 2025: Revolutionizing Cancer Treatment<\/h2> <p>Immunocore stands at the forefront of immunotherapy innovation with their groundbreaking ImmTAX platform. The company's lead product, KIMMTRAK, has become the standard of care for metastatic uveal melanoma in 28 countries, with approvals in 39 countries worldwide.<\/p> <p>The ImmTAX platform represents a quantum leap in medicine - it can target approximately <strong>90% of disease targets<\/strong> that were previously inaccessible to traditional therapies. This modular system can be configured to either upregulate the immune system (for cancer\/infectious diseases) or downregulate it (for autoimmune conditions).<\/p> <p><strong>2025 fun fact<\/strong>: Immunocore's technology originated from University of Oxford research in the 1990s, and they've since partnered with giants like Genentech, GSK, and the Bill & Melinda Gates Foundation. Their headquarters might not have perfume-dispensing elevators like L'Or\u00e9al, but they're busy developing treatments that could save millions of lives!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Immunocore Stock: Current Price and Market Position<\/h2>\n<p>As of August 30, 2025, Immunocore Holdings plc (IMCR) trades at <strong>$32.65<\/strong> on the NASDAQ exchange. The company has demonstrated remarkable resilience in the volatile biotech sector, maintaining a strong cash position of <strong>$883 million<\/strong> while driving impressive revenue growth.<\/p>\n<p><strong>Mark your calendar: November 5, 2025<\/strong> is absolutely critical for IMCR investors. That&#8217;s when the company releases its Q3 earnings report, and historically, these announcements create significant price movements.<\/p>\n<h3>How Earnings Reports Move IMCR Stock<\/h3>\n<p>Immunocore has built a reputation for beating analyst expectations. Their Q2 2025 results showed an earnings per share of -$0.20, exceeding consensus estimates of -$0.21 by $0.01. Even more impressive was their previous quarter where they delivered $0.10 per share, smashing the expected -$0.35 with a stunning <strong>128.57% positive surprise<\/strong> (<a href=\"https:\/\/tickernerd.com\/stock\/imcr-forecast\/\">Tickernerd<\/a>).<\/p>\n<p>The pattern is clear: when Immunocore beats expectations, the market rewards them. Their Q2 2025 revenue reached $130.65 million, representing a <strong>30% year-over-year increase<\/strong> and exceeding consensus estimates of $122.96 million (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/IMCR\/earnings\/\">MarketBeat<\/a>).<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Volatility Analysis<\/h2>\n<p>Immunocore shares have navigated a challenging but ultimately stable path over the past six months. The stock has traded within a <strong>52-week range of $23.15 to $39.33<\/strong>, with the current price positioned near the middle of this range (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/IMCR\/immunocore-holdings\/stock-price-history\">Macrotrends<\/a>).<\/p>\n<p><strong>Key volatility insights:<\/strong><\/p>\n<ul>\n<li>Daily volatility averages <strong>2.47%<\/strong> over the past week<\/li>\n<li>Weekly volatility sits at <strong>4.5%<\/strong>, significantly lower than the biotech industry average of 10.6%<\/li>\n<li>The stock shows only <strong>47% green days<\/strong> over the past month with 10.27% price volatility<\/li>\n<\/ul>\n<p>Despite some downward pressure, IMCR has maintained <strong>technical support at $35.63<\/strong> based on volume accumulation, providing a potential buying opportunity if tested (<a href=\"https:\/\/stockinvest.us\/stock\/IMCR\">StockInvest<\/a>).<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<h3>Near-Term Projections (2025-2026)<\/h3>\n<p>For 2025, analysts project an <strong>average price target of $47.23<\/strong>, with optimistic scenarios reaching <strong>$65.65<\/strong> and conservative estimates around <strong>$28.80<\/strong> (<a href=\"https:\/\/stockscan.io\/stocks\/IMCR\/forecast\">Stockscan<\/a>). The current analyst consensus among 7 experts is a <strong>&#8220;Buy&#8221; rating with an average target of $57<\/strong> &#8211; representing a potential <strong>74.58% upside<\/strong> from current levels.<\/p>\n<h3>Medium to Long-Term Forecast<\/h3>\n<ul>\n<li><strong>2026<\/strong>: Expected to continue growth trajectory toward $50-60 range<\/li>\n<li><strong>2028<\/strong>: Projected to reach $70-85 as pipeline products mature<\/li>\n<li><strong>2030<\/strong>: Analysts forecast <strong>$90.85<\/strong> based on platform expansion and market penetration<\/li>\n<\/ul>\n<p><strong>Verdict: STRONG BUY<\/strong> for long-term investors. The combination of strong revenue growth, expanding pipeline, and massive addressable markets makes IMCR an compelling opportunity for patient capital.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>High RSI<\/strong>: Current RSI14 reading of <strong>81<\/strong> indicates overbought conditions<\/li>\n<li><strong>Profitability challenges<\/strong>: Negative EPS of -$0.41 and forward P\/E of -26.71<\/li>\n<li><strong>Clinical trial risks<\/strong>: Phase 3 trials carry inherent uncertainty<\/li>\n<li><strong>Regulatory hurdles<\/strong>: FDA approvals can be unpredictable in biotech<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Revenue explosion<\/strong>: KIMMTRAK sales grew <strong>30% year-over-year<\/strong> to $98.0 million in Q2<\/li>\n<li><strong>Cash fortress<\/strong>: $883 million war chest provides 5+ years of runway<\/li>\n<li><strong>Pipeline progress<\/strong>: Phase 3 TEBE-AM trial on track for H1 2026 completion<\/li>\n<li><strong>Industry tailwinds<\/strong>: Cancer immunotherapy market growing at 15% annually<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong>: Begin with a position size that represents \u22645% of your portfolio<\/li>\n<li><strong>Dollar-cost average<\/strong>: Invest fixed amounts monthly to avoid timing mistakes<\/li>\n<li><strong>Set price alerts<\/strong>: Monitor around November 5 earnings for potential entry points<\/li>\n<li><strong>Think long-term<\/strong>: Biotech investments require 3-5 year time horizons<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading IMCR is like watching a clinical trial &#8211; 90% waiting, 10% excitement, but when it works, it really works!&#8221;<\/p>\n<h2>\u2705 How to Buy Immunocore Holdings plc (IMCR) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ access and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Typically requires ID and proof of address<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;IMCR&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control entry price<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission rates before finalizing<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor your position<\/td>\n<td>Set stop-losses and profit targets<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>Pocket Option makes stock investing accessible for everyone:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; perfect for testing strategies risk-free<\/li>\n<li><strong>1-minute KYC process<\/strong> &#8211; upload any ID document and start trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; including cryptocurrencies, e-wallets, and bank cards<\/li>\n<li><strong>Fractional shares available<\/strong> &#8211; invest in expensive stocks with small amounts<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface and educational resources make it ideal for beginners learning how to buy Immunocore Holdings plc (IMCR) shares and other biotech stocks.<\/p>\n<h2>\ud83c\udf0d Immunocore in 2025: Revolutionizing Cancer Treatment<\/h2>\n<p>Immunocore stands at the forefront of immunotherapy innovation with their groundbreaking ImmTAX platform. The company&#8217;s lead product, KIMMTRAK, has become the standard of care for metastatic uveal melanoma in 28 countries, with approvals in 39 countries worldwide.<\/p>\n<p>The ImmTAX platform represents a quantum leap in medicine &#8211; it can target approximately <strong>90% of disease targets<\/strong> that were previously inaccessible to traditional therapies. This modular system can be configured to either upregulate the immune system (for cancer\/infectious diseases) or downregulate it (for autoimmune conditions).<\/p>\n<p><strong>2025 fun fact<\/strong>: Immunocore&#8217;s technology originated from University of Oxford research in the 1990s, and they&#8217;ve since partnered with giants like Genentech, GSK, and the Bill &#038; Melinda Gates Foundation. Their headquarters might not have perfume-dispensing elevators like L&#8217;Or\u00e9al, but they&#8217;re busy developing treatments that could save millions of lives!<\/p>\n"},"faq":[{"question":"What is Immunocore's main business?","answer":"Immunocore develops transformative immunotherapies using their proprietary ImmTAX platform to treat cancer, infectious diseases, and autoimmune conditions."},{"question":"Is Immunocore profitable?","answer":"Not yet - the company is still in growth phase with negative EPS, but they're showing strong revenue growth and reducing losses quarter-over-quarter."},{"question":"What makes IMCR a good investment?","answer":"Their revolutionary technology platform, strong revenue growth, massive addressable markets, and $883 million cash position create compelling long-term potential."},{"question":"How volatile is IMCR stock?","answer":"Moderately volatile for a biotech stock - 4.5% weekly volatility vs industry average of 10.6%, making it relatively stable in its sector."},{"question":"When should I consider buying IMCR?","answer":"Consider dollar-cost averaging into positions, with special attention around earnings dates like November 5, 2025 for potential opportunities."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is Immunocore's main business?","answer":"Immunocore develops transformative immunotherapies using their proprietary ImmTAX platform to treat cancer, infectious diseases, and autoimmune conditions."},{"question":"Is Immunocore profitable?","answer":"Not yet - the company is still in growth phase with negative EPS, but they're showing strong revenue growth and reducing losses quarter-over-quarter."},{"question":"What makes IMCR a good investment?","answer":"Their revolutionary technology platform, strong revenue growth, massive addressable markets, and $883 million cash position create compelling long-term potential."},{"question":"How volatile is IMCR stock?","answer":"Moderately volatile for a biotech stock - 4.5% weekly volatility vs industry average of 10.6%, making it relatively stable in its sector."},{"question":"When should I consider buying IMCR?","answer":"Consider dollar-cost averaging into positions, with special attention around earnings dates like November 5, 2025 for potential opportunities."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Immunocore Holdings plc (IMCR) shares - Investment in Immunocore Holdings plc (IMCR) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Immunocore Holdings plc (IMCR) shares - Investment in Immunocore Holdings plc (IMCR) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T16:07:29+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Immunocore Holdings plc (IMCR) shares &#8211; Investment in Immunocore Holdings plc (IMCR) stock\",\"datePublished\":\"2025-08-30T16:07:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\",\"name\":\"How to buy Immunocore Holdings plc (IMCR) shares - Investment in Immunocore Holdings plc (IMCR) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-30T16:07:29+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Immunocore Holdings plc (IMCR) shares &#8211; Investment in Immunocore Holdings plc (IMCR) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Immunocore Holdings plc (IMCR) shares - Investment in Immunocore Holdings plc (IMCR) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Immunocore Holdings plc (IMCR) shares - Investment in Immunocore Holdings plc (IMCR) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T16:07:29+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Immunocore Holdings plc (IMCR) shares &#8211; Investment in Immunocore Holdings plc (IMCR) stock","datePublished":"2025-08-30T16:07:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/","name":"How to buy Immunocore Holdings plc (IMCR) shares - Investment in Immunocore Holdings plc (IMCR) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-30T16:07:29+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Immunocore Holdings plc (IMCR) shares &#8211; Investment in Immunocore Holdings plc (IMCR) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":361119,"slug":"how-to-buy-immunocore-holdings","post_title":"Comment acheter des actions Immunocore Holdings plc (IMCR) - Investir dans les actions Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"it_IT":{"locale":"it_IT","id":361117,"slug":"how-to-buy-immunocore-holdings","post_title":"Come acquistare azioni Immunocore Holdings plc (IMCR) - Investire in azioni Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"pl_PL":{"locale":"pl_PL","id":361118,"slug":"how-to-buy-immunocore-holdings","post_title":"Jak kupi\u0107 akcje Immunocore Holdings plc (IMCR) - Inwestycja w akcje Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"es_ES":{"locale":"es_ES","id":361121,"slug":"how-to-buy-immunocore-holdings","post_title":"C\u00f3mo comprar acciones de Immunocore Holdings plc (IMCR) - Inversi\u00f3n en acciones de Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"th_TH":{"locale":"th_TH","id":361123,"slug":"how-to-buy-immunocore-holdings","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Immunocore Holdings plc (IMCR) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"tr_TR":{"locale":"tr_TR","id":361124,"slug":"how-to-buy-immunocore-holdings","post_title":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"vt_VT":{"locale":"vt_VT","id":361122,"slug":"how-to-buy-immunocore-holdings","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Immunocore Holdings plc (IMCR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"pt_AA":{"locale":"pt_AA","id":361120,"slug":"how-to-buy-immunocore-holdings","post_title":"Como comprar a\u00e7\u00f5es da Immunocore Holdings plc (IMCR) - Investimento em a\u00e7\u00f5es da Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-immunocore-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/360960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=360960"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/360960\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=360960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=360960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=360960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}